OTHER INFORMATION.
+Added: During the quarter ended June 30, 2024, no director
+Added: or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,”
+Added: as each term is defined in Item 408(a) of Regulation S-K.
+Added: We received a letter from the SEC, dated July
+Added: 10, 2024, which contained comments from the SEC relating to our Annual Report on Form 10-K for the fiscal year ended December 31, 2023,
+Added: or the 2023 10-K.
+Added: In response to such comments, we filed amendments to the 2023 10-K on July 24, 2024 and on August 8, 2024.
+Added: The SEC has requested that we provide additional
+Added: discussions and disclosures, including those related to:
+Added: accounts receivable and roll forward for allowance for credit losses balances;
+Added: amounts and statistics for accounts receivable factored (sold) to third party(s);
+Added: collection financial information;
+Added: settlement amounts
+Added: and statistics for amounts written off and charged to bad debt expense;
+Added: and the accounting treatment of current assets based on our normal
+Added: operating cycle.
+Added: Additionally, we received a letter from the SEC,
+Added: dated August 16, 2024, which contained comments from the SEC relating to our Quarterly Report on Form 10-Q for the fiscal quarter ended
+Added: June 30, 2024, or the 2024 Q2 10-Q.
+Added: In response to such comments, we filed amendments to the 2024 Q2 and the Quarterly Report on Form
+Added: 10-Q for the fiscal quarter ended March 31, 2024 on October 9, 2024.
+Added: The SEC requested that we provide additional discussions
+Added: and disclosures, including those related to:
+Added: revenue recognition;
+Added: our types of and accounting for variable consideration;
+Added: accounts receivable
+Added: and allowance for credit losses;
+Added: settlement amounts and statistics for amounts written off and charged to bad debt expense;
+Added: our accounting
+Added: for the correction of an error.
Amended and Restated Articles of Incorporation Cardiff Lexington Corporation (incorporated by reference to Exhibit 3.1 to Amendment No.
29 unchanged sentences
Common Stock Purchase Warrant issued by Cardiff Lexington Corporation to SILAC Insurance Company on May 21, 2021 (incorporated by reference to Exhibit 4.2 to the Annual Report on Form 10-K filed on June 6, 2023)
+Added: Settlement Agreement and Release of Claims, dated June 11, 2024, between Cardiff Lexington Corporation and GHS Investments, LLC (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on June 11, 2024)
+Added: Fixed Amount Settlement Promissory Note issued by Cardiff Lexington Corporation to GHS Investments, LLC on June 11, 2024 (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on June 11, 2024)
+Added: Securities Exchange Agreement, dated May 13, 2024, between Cardiff Lexington Corporation and Leonite Capital LLC (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on May 14, 2024)
+Added: Security and Pledge Agreement, dated May 13, 2024, among Cardiff Lexington Corporation, Nova Ortho and Spine, LLC, Edge View Properties, Inc.
+Added: and Leonite Capital LLC (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on May 14, 2024)
Certifications of Principal Executive Officer filed pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
26 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.